pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4653 |
Genomic Coordinates | chr7: 101159473 - 101159555 |
Description | Homo sapiens miR-4653 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4653-5p | |||||||||||||||||||||||||||
Sequence | 10| UCUCUGAGCAAGGCUUAACACC |31 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | DDX3X | ||||||||||||||||||||
Synonyms | CAP-Rf, DBX, DDX14, DDX3, HLP2, MRX102 | ||||||||||||||||||||
Description | DEAD-box helicase 3, X-linked | ||||||||||||||||||||
Transcript | NM_001356 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on DDX3X | |||||||||||||||||||||
3'UTR of DDX3X (miRNA target sites are highlighted) |
>DDX3X|NM_001356|3'UTR 1 GCCTGCTTTGCAGTAGGTCACCCTGCCAAACAAGCTAATATGGAAACCACATGTAACTTAGCCAGACTATACCTTGTGTA 81 GCTTCAAGAACTCGCAGTACATTACCAGCTGTGATTCTCCACTGAAATTTTTTTTTTAAGGGAGCTCAAGGTCACAAGAA 161 GAAATGAAAGGAACAATCAGCAGCCCTGTTCAGAAGGTGGTTTGAAGACTTCATTGCTGTAGTTTGGATTAACTCCCCTC 241 CCGCCTACCCCCATCCCAAACTGCATTTATAATTTTGTGACTGAGGATCATTTGTTTGTTAATGTACTGTGCCTTTAACT 321 TTAGACAACTTTTTATTTTGATGTCCTGTTGGCTCAGTAATGCTCAAGATATCAATTGTTTTGACAAAATAAATTTACTG 401 AACTTGGGCTAAAATCAAACCTTGGCACACAGGTGTGATACAACTTAACAGGAATCATCGATTCATCCATAAATAATATA 481 AGGAAAAACTTATGCGGTAGCCTGCATTAGGGCTTTTTGATACTTGCAGATTGGGGGAAAACAACAAATGTCTTGAAGCA 561 TATTAATGGAATTAGTTTCTAATGTGGCAAACTGTATTAAGTTAAAGTTCTGATTTGCTCACTCTATCCTGGATAGGTAT 641 TTAGAACCTGATAGTCTTTAAGCCATTCCAGTCATGATGAGGTGATGTATGAATACATGCATACATTCAAAGCACTGTTT 721 TCAAAGTTAATGCAAGTAAATACAGCAATTCCTCTTTCAACGTTTAGGCAGATCATTAATTATGAGCTAGCCAAATGTGG 801 GCATACTATTACAGGGAAAGTTTAAAGGTCTGATAACTTGAAATAGGTTTTTAGGAGAATTCATCTACTTAGACTTTTTA 881 AATGCCTGCCATAAATGAAATTGAAATGGTAGAATGGCTGACCACAGCAATGACCAGCCCTCATTAGGGCCCTGGATGAT 961 TTTTGGTCTAATAACGCATGCTAGTGTTGATGTTTTTTGGTCAAGAGGGTATGAACAGGAAGAATTAAATGCAGCAGGCT 1041 TTATTTTAAATGCCGATTCACATTACTCTGTTCAAGCTGCGTTGAGATGTTAAACTGGCTTACTATAGACTTCGTAAAAA 1121 TGGCTCCAGAAGAGTAACAAACTGAAATCTTTGAGATCACACAGGTTGGAAATATGTACATAACTGCACAAGGTGTCAAT 1201 TCTGCTCTACAGTGCAGTTTTAGTCAGTTTTAGTTGCATAGGTTTCCATTGTATTTATAGTCTGTTTATGCTAAATCTGG 1281 CCAAAGATGAGCATTGTCCACCACTAAAATGCCTCTGCCACTTTGAATTCTGTGCTAATTTTGTGGCCAGAATGCGGTGA 1361 TCAAAACGCTCCATCTTTTTACAGTGGCATAGGAAGACGGCAAAAATTTCCTAAAGTGCAATAGATTTTCAAGTGTATTG 1441 TGCCTTGTTCTAAAACTTTTATTAAGTAGGTGCACTTGACAGTATTGAGGTCATTTGTTATGGTGCTATTTCAATTAGTC 1521 TAGGTTTAGGCCCTTGTACATTTTGCCCATAACTTTTTACAAAGTACTTCTTTTATTGCACATTCAGAGAATTTTATATA 1601 TATGTCTTGTGTGCGTGTCCTTAAACTTCCAATCTTACTTTGTCTCTTGGAGATTGTTGAACGCAGCTTGTCTAGGAAGG 1681 GGATGGGACTAGATTCTAAAATTTATTTGGGACCATGGGAATGATAGTTGGGAAGAAAACTATTTGCACACGACAGATTT 1761 CTAGATACTTTTTGCTGCTAGTTTTATGTAATATTTATTGAACATTTTGACAAATATTTATTTTTGTAAGCCTAAAAGTG 1841 ATTCTTTGAAAGTTTAAAGAAACTTGACCAAAAGACAGTACAAAAACACTGGCACTTGAATGTTGAATGTCACCGTATGC 1921 GTGAAATTATATATTTCGGGGTAGTGTGAGCTTTTAATGTTTAAGTCATATTAAACTCTTAAGTCAAATTAAGCAGACCC 2001 GGCGTTGGCAGTGTAGCCATAACTTTCTGATGTTAGTAAAAACAAAATTGGCGACTTGAAATTAAATCATGCCAAGGTTT 2081 TGATACACTTGTCTTAAGATATTAATGAAACACTTCAAAACACTGATGTGAAGTGTCCAGATTCTCAGATGTTTGTTGTG 2161 TGGATTTTGTTTAGTTGTGTGTTTTTTTTTTTTTTTCAGTGAATGTCTGGCACATTGCAATCCTCAAACATGTGGTTATC 2241 TTTGTTGTATTGGCATAATCAGTGACTTGTACATTCAGCAATAGCATTTGAGCAAGTTTTATCAGCAAGCAATATTTTCA 2321 GTTAATAAGGTTTCAAAAATCATGTAAGGATTTAAACTTGCTGAATGTAAAGATTGAACCTCAAGTCACTGTAGCTTTAG 2401 TAATTGCTTATTGTATTAGTTTAGATGCTAGCACTGCATGTGCTGTGCATATTCTGATTTTATTAAAATAAAAAGTTGAA 2481 CTGCACAGTCTCCTTTGTTGTTGTCAATTGTGGTTTATTTTCAGAGGTGTAAATAAAGTGCTCTTGCCTGAAAAATTGTA 2561 AAATGTTAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 1654.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 1654.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 1654.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_001193416 | 3UTR | CACAUUCAGAGAAUUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_001356 | 3UTR | CAUUCAGAGAAUUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_001356 | 3UTR | UUUUAUUGCACAUUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000399959.2 | 3UTR | UACUUCUUUUAUUGCACAUUCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000399959.2 | 3UTR | UACUUCUUUUAUUGCACAUUCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000399959.2 | 3UTR | UACUUCUUUUAUUGCACAUUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000399959.2 | 3UTR | ACAUUUUGCCCAUAACUUUUUACAAAGUACUUCUUUUAUUGCACAUUCAGAGAAUUUUAUAUAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000399959.2 | 3UTR | UACUUCUUUUAUUGCACAUUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000399959.2 | 3UTR | UUGUACAUUUUGCCCAUAACUUUUUACAAAGUACUUCUUUUAUUGCACAUUCAGAGAAUUUUAUAUAUAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000399959.2 | 3UTR | CCCAUAACUUUUUACAAAGUACUUCUUUUAUUGCACAUUCAGAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000399959.2 | 3UTR | CCCAUAACUUUUUACAAAGUACUUCUUUUAUUGCACAUUCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000399959.2 | 3UTR | UACUUCUUUUAUUGCACAUUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
78 hsa-miR-4653-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT118186 | ZNF544 | zinc finger protein 544 | ![]() |
![]() |
2 | 2 | ||||||
MIRT332935 | PRKAB2 | protein kinase AMP-activated non-catalytic subunit beta 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT442166 | ARL10 | ADP ribosylation factor like GTPase 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT442387 | CLVS2 | clavesin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT442595 | SIX1 | SIX homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448014 | HLA-DOA | major histocompatibility complex, class II, DO alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT448061 | MMP15 | matrix metallopeptidase 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489017 | C1QTNF6 | C1q and TNF related 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT494456 | BTG2 | BTG anti-proliferation factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495650 | SLC35B2 | solute carrier family 35 member B2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT504016 | ACSL6 | acyl-CoA synthetase long chain family member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT506777 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 4 | ||||||
MIRT507229 | FOXN2 | forkhead box N2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT512550 | MFN2 | mitofusin 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT512842 | A1CF | APOBEC1 complementation factor | ![]() |
![]() |
2 | 6 | ||||||
MIRT513944 | DDX3X | DEAD-box helicase 3, X-linked | ![]() |
![]() |
2 | 8 | ||||||
MIRT516103 | GADL1 | glutamate decarboxylase like 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT519831 | ZFP69B | ZFP69 zinc finger protein B | ![]() |
![]() |
2 | 4 | ||||||
MIRT523210 | HIST1H3E | histone cluster 1 H3 family member e | ![]() |
![]() |
2 | 2 | ||||||
MIRT525008 | ACTN4 | actinin alpha 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT528858 | PKP1 | plakophilin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT529062 | ZNF675 | zinc finger protein 675 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531719 | TARS | threonyl-tRNA synthetase | ![]() |
![]() |
2 | 2 | ||||||
MIRT534039 | STK4 | serine/threonine kinase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT543848 | APIP | APAF1 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT545866 | ZNF264 | zinc finger protein 264 | ![]() |
![]() |
2 | 4 | ||||||
MIRT556037 | MXD1 | MAX dimerization protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557081 | HOXB3 | homeobox B3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561345 | ZBTB18 | zinc finger and BTB domain containing 18 | ![]() |
![]() |
2 | 2 | ||||||
MIRT562705 | ZNF415 | zinc finger protein 415 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563223 | ZNF286A | zinc finger protein 286A | ![]() |
![]() |
2 | 2 | ||||||
MIRT563860 | ZNF616 | zinc finger protein 616 | ![]() |
![]() |
2 | 4 | ||||||
MIRT563879 | PAGR1 | PAXIP1 associated glutamate rich protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564652 | ZNF487P | zinc finger protein 487 | ![]() |
1 | 1 | |||||||
MIRT566595 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570878 | ZFP1 | ZFP1 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT573067 | TRIB1 | tribbles pseudokinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573941 | ZNF708 | zinc finger protein 708 | ![]() |
![]() |
2 | 2 | ||||||
MIRT575966 | Slfn5 | schlafen 5 | ![]() |
![]() |
2 | 5 | ||||||
MIRT607293 | CD300E | CD300e molecule | ![]() |
![]() |
2 | 4 | ||||||
MIRT608187 | ERBB2 | erb-b2 receptor tyrosine kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT609537 | ADPRH | ADP-ribosylarginine hydrolase | ![]() |
![]() |
2 | 2 | ||||||
MIRT610152 | PRMT8 | protein arginine methyltransferase 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT611571 | SLFN5 | schlafen family member 5 | ![]() |
![]() |
2 | 7 | ||||||
MIRT613335 | AGO2 | argonaute 2, RISC catalytic component | ![]() |
![]() |
2 | 4 | ||||||
MIRT616560 | ZNF512B | zinc finger protein 512B | ![]() |
![]() |
2 | 2 | ||||||
MIRT617240 | SPATS2 | spermatogenesis associated serine rich 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618011 | SLC9A3R2 | SLC9A3 regulator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618478 | IL17REL | interleukin 17 receptor E like | ![]() |
![]() |
2 | 2 | ||||||
MIRT619099 | IFI44L | interferon induced protein 44 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT622265 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT623080 | NME6 | NME/NM23 nucleoside diphosphate kinase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625621 | LILRB2 | leukocyte immunoglobulin like receptor B2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT627844 | PLEKHA6 | pleckstrin homology domain containing A6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT630459 | GMPS | guanine monophosphate synthase | ![]() |
![]() |
2 | 2 | ||||||
MIRT630524 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | ![]() |
![]() |
2 | 4 | ||||||
MIRT631502 | TAF8 | TATA-box binding protein associated factor 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634537 | MRPS17 | mitochondrial ribosomal protein S17 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638807 | DCTN3 | dynactin subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641303 | SLAMF1 | signaling lymphocytic activation molecule family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648347 | PPP1R16B | protein phosphatase 1 regulatory subunit 16B | ![]() |
![]() |
2 | 2 | ||||||
MIRT649705 | ZNF175 | zinc finger protein 175 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652554 | TLX1 | T-cell leukemia homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT655564 | P2RX7 | purinergic receptor P2X 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT659065 | DEPTOR | DEP domain containing MTOR interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT660341 | BCAT1 | branched chain amino acid transaminase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664330 | RAB8A | RAB8A, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT688934 | ATXN7L3B | ataxin 7 like 3B | ![]() |
![]() |
2 | 2 | ||||||
MIRT689971 | ZNF185 | zinc finger protein 185 with LIM domain | ![]() |
![]() |
2 | 2 | ||||||
MIRT699514 | SKIL | SKI like proto-oncogene | ![]() |
![]() |
2 | 2 | ||||||
MIRT699975 | RREB1 | ras responsive element binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702676 | IRS2 | insulin receptor substrate 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT709357 | ULK2 | unc-51 like autophagy activating kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT709837 | PAQR7 | progestin and adipoQ receptor family member 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718716 | ANKRD18A | ankyrin repeat domain 18A | ![]() |
![]() |
2 | 2 | ||||||
MIRT718879 | PDIA3 | protein disulfide isomerase family A member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724105 | TMEM199 | transmembrane protein 199 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724763 | PSG4 | pregnancy specific beta-1-glycoprotein 4 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|